Pat Sharp

Company: Gate Bioscience

Job title: Co-Founder

Seminars:

New Approach for TPD: Targeting the Secretory Translocon (Sec61) to Selectively Eliminate Extracellular Proteins 3:00 pm

Mother Nature pioneered targeting of Sec61 for secretory protein degradation Selectivity is enabled by virtue of the unique sequences of Signal Peptides across the secretome Synthetic small molecules are capable of selectively eliminating secreted and membrane proteinsRead more

day: Post-Conference Focus Day